Table 1

Clinical characteristics of 26 patients with central retinal vein occlusion before fibrinolysis treatment

Case	Age	Sex	Glaucoma/ IOP >21 mm Hg	Duration of visual loss (days)	Initial VA	Cause of visual loss	VA at day 1	Last VA	Rubeosis/ NVG	Follow up (months)
1	66	F	Yes	0.5	CF	IBF	20/40	20/50	—	16
2	53	M	—	1	20/400	IBF	20/50	20/20	—	6
3	45	M	—	0.5	CF	IBF	20/20	20/20	—	5
4	67	M	Yes	2	20/160	IBF	20/100	20/50	—	4
5	59	M	—	11	CF	IBF	CF	CF	Rubeosis	28
6	44	M	—	2	CF	IBF	CF	CF	—	3
7	58	F	—	0.5	CF	IBF	CF	20/200	—	3
8	51	M	—	2	CF	IBF	CF	20/200	—	3
9	56	F	Yes	0.5	CF	IBF	LP	LP	—	6
10	42	M	—	30	20/50	MO	20/25	20/200	—	22
11	69	M	—	2	CF	MO	CF	CF	Rubeosis	15
12	45	F	—	4	CF	MO	20/200	20/20	—	14
13	85	M	—	3	CF	MO	HM	HM	—	2
14	65	M	—	5	20/100	MO	20/100	20/200	—	7
15	75	F	—	120	CF	MO	CF	20/400	—	32
16	58	M	—	210	20/50	MO	20/50	20/60	—	53
17	61	M	Yes	30	20/50	MO	20/40	CF	—	18
18	56	M	—	60	20/100	MO	20/100	20/100	—	71
19	57	M	Yes	90	20/50	MO	20/50	20/400	NVG	31
20	65	M	—	60	20/400	MO	20/400	20/400		4
21	69	F	Yes	5	20/50	MO	20/40	20/25		6
22	52	M	—	1	20/60	CR	20/25	20/25		34
23	73	M	Yes	18	20/25	CR	20/40	20/20		32
24	60	M	—	7	20/160	CR	20/160	20/200		4
25	50	M	Yes	2	CF	SMH	CF	HM	Rubeosis	3
26	73	F	—	15	CF	Ischaemia	HM	HM	NVG	32

NVG = neovascular glaucoma; IBF = impairment of retinal blood flow; MO = macular oedema; CR = cilioretinal artery occlusion; SMH = submacular haemorrhage.